Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia
- PMID: 18483755
- DOI: 10.1007/s10096-008-0518-2
Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia
Abstract
Severe infections caused by Stenotrophomonas maltophilia are associated with high mortality, and strategies to improve the clinical outcome for infected patients are needed. A retrospective cohort study of patients with bloodstream infection (BSIs) and pneumonia caused by S. maltophilia was conducted. Multivariate analysis was performed to access factors associated with 14-day mortality. A total of 60 infections were identified. Among these, eight (13%) were pneumonias and 52 were BSIs; 33.3% were primary, 13% were central venous catheter (CVC)-related and 40% were secondary BSIs. Fifty-seven (85%) patients had received previous antimicrobial therapy; 88% had CVC, 57% mechanical ventilation and 75% were in the intensive care unit at the onset of infection. Malignancy (45%) was the most frequent underlying disease. The mean of the Acute Physiology and Chronic Health Evaluation II (APACHE II) scores was 17 and for the Sepsis-related Organ Failure Assessment (SOFA) score, it was 7 points. The overall and 14-day mortality were, respectively, 75% and 48%. Forty-seven (78%) patients were treated and, of these, 74% received trimethoprim-sulfamethoxazole. Independent risk factors associated with mortality were SOFA index >6 points (0.005) and septic shock (0.03). The Kaplan-Meier estimations curves showed that patients with APACHE II score >20 and SOFA score >10 had a survival chance of, respectively, less than 8% and less than 10% (P<or=0.001) at 21 days after the first positive S. maltophilia culture. Our results suggest that the independent factors associated with outcome in patients with infection caused by S. maltophilia are septic shock and higher SOFA index.
Similar articles
-
Mortality rates and risk factors associated with mortality in patients with stenotrophomonas maltophilia primary Bacteraemia and Pneumonia.Diagn Microbiol Infect Dis. 2025 Mar;111(3):116664. doi: 10.1016/j.diagmicrobio.2024.116664. Epub 2024 Dec 21. Diagn Microbiol Infect Dis. 2025. PMID: 39729953
-
Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review.J Hosp Infect. 2008 Oct;70(2):101-8. doi: 10.1016/j.jhin.2008.05.020. Epub 2008 Jul 14. J Hosp Infect. 2008. PMID: 18621440
-
Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1419-28. doi: 10.1007/s10096-011-1459-8. Epub 2011 Nov 7. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22057419
-
Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.J Hosp Infect. 2012 Jun;81(2):114-8. doi: 10.1016/j.jhin.2012.02.008. Epub 2012 Apr 10. J Hosp Infect. 2012. PMID: 22494851
-
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.Clin Microbiol Infect. 2019 May;25(5):546-554. doi: 10.1016/j.cmi.2018.11.008. Epub 2018 Nov 16. Clin Microbiol Infect. 2019. PMID: 30448331
Cited by
-
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study.Crit Care. 2019 Nov 21;23(1):371. doi: 10.1186/s13054-019-2649-5. Crit Care. 2019. PMID: 31752976 Free PMC article.
-
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review.Infect Dis Ther. 2025 Mar;14(3):657-669. doi: 10.1007/s40121-025-01117-2. Epub 2025 Mar 4. Infect Dis Ther. 2025. PMID: 40032812 Free PMC article.
-
Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia.Appl Environ Microbiol. 2013 Sep;79(18):5593-600. doi: 10.1128/AEM.01648-13. Epub 2013 Jul 8. Appl Environ Microbiol. 2013. PMID: 23835182 Free PMC article.
-
Type II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2.Infect Immun. 2015 Oct;83(10):3825-37. doi: 10.1128/IAI.00672-15. Epub 2015 Jul 13. Infect Immun. 2015. PMID: 26169274 Free PMC article.
-
Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Patients with Stenotrophomonas maltophilia Bacteremia.J Clin Med. 2022 May 30;11(11):3085. doi: 10.3390/jcm11113085. J Clin Med. 2022. PMID: 35683471 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources